Hearing Loss in Children with Osteogenesis Imperfecta (OI) Treated with Bisphosphonates
β Scribed by Christi A. Arnerich; Aaron C. Moberly; Linda A. Dimeglio; Richard T. Miyamoto
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 582 KB
- Volume
- 119
- Category
- Article
- ISSN
- 0023-852X
No coin nor oath required. For personal study only.
β¦ Synopsis
21.4% of children developed hearing loss, a percentage similar to previous population studies.
β’ Since all received treatment, we cannot determine directly bisphosphonate effects on hearing loss over time. β’ However, it appears that bisphosphonates neither increase hearing loss nor stop progression in these children.
π SIMILAR VOLUMES
Osteogenesis imperfecta (OI) is a heritable bone fragility disorder characterized by skeletal deformities and increased bone fragility. There is currently no established clinical method for quantifying fracture risk in OI patients. This study begins the development of a patient-specific model for fe
## Abstract Williams syndrome (WS) is a genetic neurodevelopmental disorder, most often accompanied by mildβtoβmoderate mental retardation. Individuals with WS show unique communication strengths and impairments that are challenging to treat in community, educational, and vocational settings. Many